Mitchell W. Kitayama - 10 Jun 2026 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Reporting relationship: Director
Issuer ticker: ASTH
Reported as of: 10 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Jun 2026, 16:19:43 UTC
Prior SEC filing: 12 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Kathy Diep, as Attorney-in-Fact

Key filing fact

Mitchell W. Kitayama filed Form 4 for Astrana Health, Inc. (ASTH) on 12 Jun 2026.

Key facts

This page summarizes Mitchell W. Kitayama's Form 4 filing for Astrana Health, Inc. (ASTH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Jun 2026, 16:19.

Change

Previous filing in this sequence was filed on 12 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001333154 Primary reporting owner

Kitayama Mitchell W

Relationship: Director
Address: C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVE, 2ND FLOOR, ALHAMBRA
Signature: /s/ Kathy Diep, as Attorney-in-Fact
Signature date: 12 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASTH transaction

Common Stock

Award

Transaction value
Shares: +4,991
Change %: +18%
Price: $0.000000^*
Shares after: 32,837
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.

Footnote F2

Includes 4,991 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.